Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said. ...
Union Minister Nitin Gadkari on Tuesday said that more pharma companies should be allowed to manufacture the COVID-19 vaccine in the country during the pandemic to scale up production. ...
External Affairs Minister S Jaishankar on Wednesday said he was proud to have taken 'Covaxin' and recalled that questions were raised when the indigenous COVID-19 vaccine manufactured by Bharat Biotech came to the market earlier this year. ...
Bharat Biotech and Serum Institute of India (SII), the country's leading COVID-19 vaccine manufacturers, on Thursday submitted to the Delhi High Court that adequate capacity of vaccines were available for judicial staff, advocates and judges as front ...
